Tahoe Forest Cancer Center director speaks at Portland conference
TRUCKEE, Calif. — Dr. Laurence J. Heifetz, medical director at the Gene Upshaw Memorial Tahoe Forest Cancer Center, spoke recently at the Association of Community Cancer Centers 32nd National Oncology Conference in Portland, Ore.
His talk, titled “Putting Patients First: Leveraging Technology for Molecular Testing,” was about the virtual tumor board technology available at the cancer center in Truckee.
Dr. Heifetz was selected to speak because of the outstanding reputation of the program he leads at the Gene Upshaw Memorial Tahoe Forest Cancer Center and his experience in implementing and using this technology.
He explained how virtual tumor boards can have a significant positive effect on providing patient-centered care.
Oncology programs without a molecular testing expert on staff can leverage technology to collaborate on decision-making and best practices, improving wider access to more effective medicines for conditions that would otherwise go untreated in patients in remote areas.
Dr. Heifetz also provided attendees with background on how he and his colleagues at the UC Davis Comprehensive Cancer Center assembled the tumor board webinars, and gave attendees information on how they could replicate this practice at their facilities.
Association of Community Cancer Centers, an education and advocacy organization for multidisciplinary cancer teams, is comprised of oncologists, advanced practice providers, social workers, oncology nurses, pharmacists, cancer program administrators and managers.
For more information about Association of Community Cancer Centers, go to accc-cancer.org.
This article was submitted by the Tahoe Forest Health District. Visit tfhd.com to learn more.